Wellington Management Group’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $167M | Sell |
5,807,308
-1,084,089
| -16% | -$31.2M | 0.03% | 394 |
|
|
2025
Q1 | $231M | Sell |
6,891,397
-59,170
| -0.9% | -$1.98M | 0.04% | 315 |
|
|
2024
Q4 | $355M | Buy |
6,950,567
+2,490,876
| +56% | +$127M | 0.07% | 246 |
|
|
2024
Q3 | $228M | Sell |
4,459,691
-160,722
| -3% | -$8.21M | 0.04% | 362 |
|
|
2024
Q2 | $207M | Buy |
4,620,413
+1,648,831
| +55% | +$73.9M | 0.04% | 375 |
|
|
2024
Q1 | $139M | Sell |
2,971,582
-273,523
| -8% | -$12.8M | 0.02% | 476 |
|
|
2023
Q4 | $115M | Sell |
3,245,105
-395,130
| -11% | -$14.1M | 0.02% | 526 |
|
|
2023
Q3 | $108M | Buy |
3,640,235
+38,523
| +1% | +$1.15M | 0.02% | 503 |
|
|
2023
Q2 | $64.9M | Sell |
3,601,712
-33,814
| -0.9% | -$609K | 0.01% | 652 |
|
|
2023
Q1 | $58.4M | Buy |
3,635,526
+831,041
| +30% | +$13.3M | 0.01% | 659 |
|
|
2022
Q4 | $51.3M | Buy |
2,804,485
+171,474
| +7% | +$3.14M | 0.01% | 678 |
|
|
2022
Q3 | $51.7M | Buy |
2,633,011
+809,413
| +44% | +$15.9M | 0.01% | 663 |
|
|
2022
Q2 | $34M | Buy |
1,823,598
+794,234
| +77% | +$14.8M | 0.01% | 790 |
|
|
2022
Q1 | $22.6M | Sell |
1,029,364
-40,908
| -4% | -$898K | ﹤0.01% | 989 |
|
|
2021
Q4 | $30.4M | Buy |
1,070,272
+157,201
| +17% | +$4.47M | ﹤0.01% | 986 |
|
|
2021
Q3 | $19.2M | Buy |
913,071
+167,684
| +22% | +$3.53M | ﹤0.01% | 1101 |
|
|
2021
Q2 | $14.1M | Buy |
745,387
+193,220
| +35% | +$3.64M | ﹤0.01% | 1181 |
|
|
2021
Q1 | $8.44M | Sell |
552,167
-4,468
| -0.8% | -$68.3K | ﹤0.01% | 1284 |
|
|
2020
Q4 | $7.85M | Buy |
556,635
+118,879
| +27% | +$1.68M | ﹤0.01% | 1234 |
|
|
2020
Q3 | $6.86M | Buy |
437,756
+126,475
| +41% | +$1.98M | ﹤0.01% | 1199 |
|
|
2020
Q2 | $5.45M | Buy |
+311,281
| New | +$5.45M | ﹤0.01% | 1196 |
|